teaser
Drug giant AstraZeneca’s bipolar disorder treatment Seroquel – which is used alongside antidepressants to combat major depressive disorders (MDD) – has been approved by the US Food and Drug Administration (FDA).
A large amount of MDD sufferers do not respond well enough to treatment from antidepressants, say Astra – which is where Seroquel can help doctors follow a different course of action.
The FDA has written to Astra requesting additional information on treating MDD solely using Seroquel.
↓Article continues below this sponsored advert↓
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
↑Advertisement↑
News of Seroquel’s approval comes the day after Astra announced it is to licence TC-5214, also used to treat MDD, developed by biopharmaceutical company Targacept.
Copyright Press Association 2009
